Systematic Evaluation of Shoulder Hand Syndrome After Stroke Combined with Rehabilitation

Objective: Systematic evaluation of the effectiveness and safety of needling in combination with rehabilitation for post-stroke shoulder syndrome. Methods: Computer retrieval of Cochrane library (issue4 2014), MEDLINE (1966.1-2014.4), EMBase (1980.1-2014.4), Web of science ( 1950.1-2014.4), CBMDisc (1978.1-2014.4), CNKI (1979.1-2014.4), VIP (1989.1-2014.4), WANFANG (1998.1-2014.4), and manually retrieved the library journal “Chinese Acupuncture”, China The Journal of Rehabilitation Medicine, Needling Research, and other related journals, Screening Needles combined with randomized and semi-randomized controlled trials of Rehabilitation for the treatment of shoulder hand syndrome after stroke. Random control The trial, containing 1162 patients, Meta analysis showed: acupuncture combined with the recovery group alone, key outcome indicators FMA (Fugl-Meyer Assessment Scale) and VAS (Visual Analogue Scale): Patients with the condition phase I (3 weeks of course), in FMA [MD= 9.83,95% CI (-1.89,21.55)] and the differences in VAS [MD=-1.29,95% CI (-2.11, -0.47)]. are significant in the indicators; the condition The difference in FMA [MD=12.45,95% CI (8.25,16.65)] was significant; patients who did not stage (4 weeks of course), needling combined with the recovery group and the recovery group alone were not significant on both outcome indicators. of patients, in FMA [MD=9.35,95% Differences are significant on CI (4.19,14.51)] and also on VAS [MD=-1.88,95% CI (-3.08,0.68)]. and treatment course of patients, in Some trials have shown an advantage in pain treatment and rejuvenation of post-stroke shoulder syndrome in some trials. Since this system evaluation incorporates small, poor quality and low number of studies, the conclusions of which are largely derived from individual studies, these conclusions need to be treated with caution., large sample, high quality, long-term follow-up needling combined with rehabilitation for stroke shoulder syndrome randomization for further validation by the trial.